query
ai
Login
Registrieren
Infos
Werben auf fleebs.com
Seite indizieren lassen
Einstellungen
Datenschutz
Nutzungsbedingungen
Impressum
Details werden geladen...
https://www.medscape.com/c99/p10/oral-her2-kinase-inhibitors-reach-first-line-breast-and-lung-2026a10016qa
Teilen bei
Facebook
Teilen bei
Twitter
Teilen bei
Pinterest
Per Mail empfehlen
HER2 Tyrosine Kinase Inhibitors: Class Deep Dive
Five HER2 kinase inhibitors now span breast, lung, and colorectal cancer. Trial data and comment from Erika Hamilton, MD, show how labels, safety, and interactions differ.
Ähnliche Seiten
Managing Immune Checkpoint Inhibitor Colitis
https://www.medscape.com/viewarticle/managing-immune-checkpoint-inhibitor-colitis-guide-2026a10012o4
HER2-Directed Antibodies: 14 Products Compared
https://www.medscape.com/c99/p10/after-28-years-trastuzumab-has-competition-head-head-loss-2026a10016qk
New Cancer Drugs: Can Care Keep Up With Innovation?
https://www.medscape.com/viewarticle/new-cancer-drugs-can-care-keep-innovation-2026a10010g7
FDA Okays Tucatinib for HER2+ Breast Cancer Maintenance
https://www.medscape.com/viewarticle/fda-okays-tucatinib-her2-positive-breast-cancer-maintenance-2026a10011ng
FDA Approves Dostarlimab for Rectal Cancer
https://www.medscape.com/viewarticle/fda-approves-dostarlimab-rectal-cancer-2026a10013c7
Healthy Lifestyle Tied to Better Health After Breast Cancer
https://www.medscape.com/viewarticle/higher-alignment-lifestyle-guidelines-linked-better-physical-2026a10012qg
Please enable JavaScript to continue using this application.